Julie Wolfe

Julie’s breadth of experience in over 25 years in the life science and consulting industry provides a unique blend of analytical expertise and strategic insight to help inform critical business decisions.

Core focus areas include competitive landscape, commercial opportunity assessments, product and market prioritization, early pipeline and LCM strategy, forecasting, and Rx-to-OTC switch. Julie has served clients across a broad range of therapeutic areas, including GI, Derm, Urology, CVD, Infectious Disease, and specialty and rare disease.

Prior to joining Putnam, Julie worked for over 7 years as Head of Business Analytics for Rx-to-OTC Switch and of Competitive Intelligence at Pfizer CHC. Additionally, she has worked for Cegedim (now IQVIA), Bradley Pharm, Novartis, and as a Consultant. Julie holds an MBA in Marketing from Rutgers Graduate School of Mgmt. where she was inducted into the Beta Gamma Sigma honor society and a BA in Math and Computer Science.